Filing Details
- Accession Number:
- 0001209191-19-006612
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-01 19:08:14
- Reporting Period:
- 2019-01-30
- Accepted Time:
- 2019-02-01 19:08:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-01-30 | 25,000 | $29.34 | 364,671 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-30 | 3,101 | $72.01 | 361,570 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-30 | 10,215 | $73.12 | 351,355 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-30 | 11,418 | $74.20 | 339,937 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-30 | 266 | $74.64 | 339,671 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Acquisiton | 2019-01-31 | 25,000 | $29.34 | 364,671 | No | 4 | M | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-31 | 1,808 | $73.58 | 362,863 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-31 | 5,364 | $74.28 | 357,499 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-31 | 17,673 | $75.33 | 339,826 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Common Stock | Disposition | 2019-01-31 | 155 | $75.94 | 339,671 | No | 4 | S | Indirect | Held by the Shak Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | M | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
No | 4 | S | Indirect | Held by the Shak Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-30 | 25,000 | $0.00 | 25,000 | $29.34 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-31 | 25,000 | $0.00 | 25,000 | $29.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2022-02-05 | No | 4 | M | Direct | |
0 | 2022-02-05 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 16,250 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $71.47 to $72.45.
- Represents weighted average sale price. Actual sale prices ranged from $72.60 to $72.585.
- Represents weighted average sale price. Actual sale prices ranged from $73.60 to $74.53.
- Represents weighted average sale price. Actual sale prices ranged from $74.63 to $74.66.
- Represents weighted average sale price. Actual sale prices ranged from $72.81 to $73.80.
- Represents weighted average sale price. Actual sale prices ranged from $73.82 to $74.79.
- Represents weighted average sale price. Actual sale prices ranged from $74.88 to $75.87.
- Represents weighted average sale price. Actual sale prices ranged from $75.90 to $75.96.
- The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter.